CReATe: Investigating Biomarkers for Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia
Feb 22, 2023 ·
2m 27s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
New research from the Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium. This summary is based on a paper published in the International Journal of Molecular...
show more
New research from the Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium. This summary is based on a paper published in the International Journal of Molecular Sciences on November 3, 2022, titled "Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia Type 4."
Read the paper here: https://www.mdpi.com/1422-0067/23/21/13466
Learn more about CReATe: https://www1.rarediseasesnetwork.org/cms/create/
show less
Read the paper here: https://www.mdpi.com/1422-0067/23/21/13466
Learn more about CReATe: https://www1.rarediseasesnetwork.org/cms/create/
Information
| Author | RDCRN |
| Organization | RDCRN |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
Comments